Infusion Brands International, Inc. (INBI)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Sep 30, 2025
INBI Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2011 | FY 2010 | FY 2010 | FY 2009 | FY 2008 |
|---|---|---|---|---|---|---|
Period Ending | Sep '12 Sep 30, 2012 | Dec '11 Dec 31, 2011 | Dec '10 Dec 31, 2010 | Jun '10 Jun 30, 2010 | Jun '09 Jun 30, 2009 | Jun '08 Jun 30, 2008 |
| 14.45 | 18.18 | 8.33 | 17.8 | 9.79 | 0.97 | |
Revenue Growth (YoY) | -0.47% | 118.18% | -53.19% | 81.88% | 911.53% | 30447.03% |
Cost of Revenue | 10.77 | 10.85 | 4.58 | 9.12 | 5.15 | 0.29 |
Gross Profit | 3.69 | 7.34 | 3.76 | 8.69 | 4.64 | 0.68 |
Selling, General & Admin | 8.24 | 13.29 | 11.99 | 11.89 | 7.82 | 2.28 |
Operating Expenses | 8.54 | 13.53 | 12.87 | 13.07 | 8.47 | 2.97 |
Operating Income | -4.85 | -6.2 | -9.11 | -4.39 | -3.83 | -2.28 |
Interest Expense | -0.56 | -0.4 | -0.15 | -0.21 | -0.35 | -0.19 |
Interest & Investment Income | 0.01 | 0.13 | 0.18 | 0.32 | 0.2 | 0.03 |
Other Non Operating Income (Expenses) | 0 | - | 20.94 | 29.61 | 1.97 | 21.39 |
EBT Excluding Unusual Items | -5.4 | -6.46 | 11.86 | 25.33 | -2.01 | 18.94 |
Impairment of Goodwill | 0 | 0.2 | - | - | - | - |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -7.83 |
Asset Writedown | - | - | -3.88 | -3.88 | -0.2 | - |
Legal Settlements | 0.12 | 0.12 | -0.06 | - | - | - |
Other Unusual Items | -0.68 | -0.68 | - | -24.2 | - | -26.52 |
Pretax Income | -5.96 | -6.83 | 7.92 | -2.76 | -2.21 | -15.4 |
Income Tax Expense | 0.07 | 0.07 | - | - | - | - |
Earnings From Continuing Operations | -6.03 | -6.9 | 7.92 | -2.76 | -2.21 | -15.4 |
Earnings From Discontinued Operations | - | - | -24.23 | -28.39 | -0.54 | - |
Net Income to Company | -6.03 | -6.9 | -16.31 | -31.15 | -2.75 | -15.4 |
Minority Interest in Earnings | 0.17 | -0.05 | 0.24 | 0.34 | 0.12 | - |
Net Income | -5.87 | -6.94 | -16.07 | -30.81 | -2.63 | -15.4 |
Preferred Dividends & Other Adjustments | 23.71 | 10.9 | 1.88 | 66.95 | 2.96 | 22.91 |
Net Income to Common | -29.58 | -17.85 | -17.95 | -97.76 | -5.58 | -38.32 |
Shares Outstanding (Basic) | 181 | 178 | 159 | 138 | 15 | 14 |
Shares Outstanding (Diluted) | 181 | 178 | 215 | 138 | 15 | 14 |
Shares Change (YoY) | 5.36% | -17.33% | 56.08% | 850.76% | 2.39% | 32.98% |
EPS (Basic) | -0.16 | -0.10 | -0.11 | -0.71 | -0.39 | -2.71 |
EPS (Diluted) | -0.17 | -0.10 | -0.08 | -0.71 | -0.39 | -2.71 |
Free Cash Flow | -3.88 | -7.22 | -6.61 | -6.03 | -8.67 | -1.03 |
Free Cash Flow Per Share | -0.02 | -0.04 | -0.03 | -0.04 | -0.60 | -0.07 |
Gross Margin | 25.50% | 40.34% | 45.10% | 48.79% | 47.39% | 70.34% |
Operating Margin | -33.57% | -34.08% | -109.27% | -24.64% | -39.14% | -236.10% |
Profit Margin | -204.61% | -98.14% | -215.42% | -549.08% | -57.05% | -3959.48% |
Free Cash Flow Margin | -26.87% | -39.69% | -79.34% | -33.88% | -88.58% | -106.74% |
EBITDA | -4.56 | -5.93 | -7.74 | -2.38 | -3.22 | -1.38 |
EBITDA Margin | -31.55% | -32.59% | -92.90% | -13.38% | -32.92% | -143.06% |
D&A For EBITDA | 0.29 | 0.27 | 1.36 | 2.01 | 0.61 | 0.9 |
EBIT | -4.85 | -6.2 | -9.11 | -4.39 | -3.83 | -2.28 |
EBIT Margin | -33.57% | -34.08% | -109.27% | -24.64% | -39.14% | -236.10% |
Advertising Expenses | - | 5.33 | 4.35 | 5.84 | 5.05 | 0.28 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.